Therefore, although brain IR can manifest as an impaired ability to regulate metabolism (Arnold et al., 2018), the relationship between cerebral insulin sensitivity and glycometabolism in AD needs to be further addressed. The gene discussed is INS; the disease is Alzheimer disease.